APA (7th ed.) Citation

FR, H., LA, D. V., L, G., I, C., SJ, M., JB, S., . . . G, V. (2026). DNA-junction-based personalized liquid biopsy assays could inform management of aggressive endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 36(5), 102773. https://doi.org/10.1016/j.ijgc.2025.102773

Chicago Style (17th ed.) Citation

FR, Harris, et al. "DNA-junction-based Personalized Liquid Biopsy Assays Could Inform Management of Aggressive Endometrial Cancer." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 36, no. 5 (2026): 102773. https://doi.org/10.1016/j.ijgc.2025.102773.

MLA (9th ed.) Citation

FR, Harris, et al. "DNA-junction-based Personalized Liquid Biopsy Assays Could Inform Management of Aggressive Endometrial Cancer." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 36, no. 5, 2026, p. 102773, https://doi.org/10.1016/j.ijgc.2025.102773.